1,487
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Everyday functioning of people with Parkinson’s disease and impairments in executive function: a qualitative investigation

ORCID Icon, , & ORCID Icon
Pages 2351-2363 | Received 28 Dec 2016, Accepted 21 May 2017, Published online: 09 Jun 2017

References

  • Verleden S, Vingerhoets G, Santens P. Heterogeneity of cognitive dysfunction in Parkinson’s disease: a cohort study. Eur Neurol. 2007;58:34–40.
  • Owen AM. Cognitive dysfunction in Parkinson disease: the role of frontostriatal circuitry. Neuroscientist. 2004;10:525–537.
  • Riedel O, Klotsche J, Spottke A, et al. Cognitive impairment in 873 patients with idiopathic Parkinson’s disease. Results from the German study on epidemiology of Parkinson’s disease with dementia (GEPAD)). J Neurol. 2008;255:255–264.
  • Dalrymple-Alford JC, Livingston L, MacAskill MR, et al. Characterizing mild cognitive impairment in Parkinson’s disease. Mov Disord. 2011;26:629–636.
  • Pirozzolo FJ, Hansch EC, Mortimer JA, et al. Dementia in Parkinson’s disease. A neuropsychological analysis. Brain Cogn. 1982;1:71–83.
  • Altgassen M, Phillips L, Kopp U, et al. Role of working memory components in planning performance of individuals with Parkinson’s disease. Neuropsychologia. 2007;45:2393–2397.
  • Kliegel M, Phillips LH, Lemke U, et al. Planning and realisation of complex intentions in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatr. 2005;76:1501–1505.
  • Meiran N, Friedman G, Yehene E. Parkinson’s disease is associated with goal setting deficits during task switching. Brain Cogn. 2004;54:260–262.
  • Zgaljardic DJ, Borod JC, Foldi NS, et al. An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson’s disease. J Clin Exp Neuropsychol. 2006;28:1127–1144.
  • Mimura M, Oeda R, Kawamura M. Impaired decision-making in Parkinson’s disease. Parkinsonism Relat Disord. 2006;12:169–175.
  • Dirnberger G, Jahanshahi M. Executive dysfunction in Parkinson’s disease: a review. J Neuropsychol. 2013;7:193–224.
  • Weintraub D, Moberg PJ, Culbertson WC, et al. Dimensions of executive function in Parkinson’s disease. Dement Geriatr Cogn Disord. 2005;20:140–144.
  • Chaytor N, Schmitter-Edgecombe M. The ecological validity of neuropsychological tests: a review of the literature on everyday cognitive skills. Neuropsychol Rev. 2003;13:181–197.
  • Kudlicka A, Clare L, Hindle JV. Quality of life, health status and caregiver burden in Parkinson’s disease: relationship to executive functioning. Int J Geriatr Psychiatry. 2014;29:68–76.
  • Ceravolo R, Pagni C, Tognoni G, et al. The epidemiology and clinical manifestations of dysexecutive syndrome in Parkinson’s disease. Front Neur. 2012;3:159.
  • Reginold W, Duff-Canning S, Meaney C, et al. Impact of mild cognitive impairment on health-related quality of life in Parkinson’s disease. Dement Geriatr Cogn Disord. 2013;36:67–75.
  • Sitek EJ, Sławek J, Evans JJ. Mild cognitive impairment in Parkinson’s disease: how much testing is needed for correct diagnosis? Basal Ganglia. 2014;4:89–94.
  • Korczyn AD. Mild cognitive impairment in Parkinson’s disease. J Neural Transm (Vienna). 2013;120:517–521.
  • Burn DJ, Barker RA. Mild cognitive impairment in Parkinson’s disease: millstone or milestone? Pract Neurol. 2013;13:68–69.
  • Poliakoff E, Smith-Spark JH. Everyday cognitive failures and memory problems in Parkinson’s patients without dementia. Brain Cogn. 2008;67:340–350.
  • Brod M, Mendelsohn GA, Roberts B. Patients' experiences of Parkinson’s disease. J Gerontol B Psychol Sci Soc Sci 1998;53:213–222.
  • Copeland JN, Lieberman A, Oravivattanakul S, et al. Accuracy of patient and care partner identification of cognitive impairments in Parkinson’s disease–mild cognitive impairment. Mov Disord. 2016;31:693–698.
  • Koerts J, Tucha L, Leenders KL, et al. Subjective and objective assessment of executive functions in Parkinson’s disease. J Neurol Sci. 2011;310:172–175.
  • Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24:1641–1649.
  • Bronnick K, Ehrt U, De Deyn P, et al. Attentional deficits affect activities of daily living in dementia-associated with Parkinson’s disease. J Neurol Neurosurg Psychiatr. 2006;77:1136–1142.
  • Cahn DA, Sullivan EV, Shear PK, et al. Differential contributions of cognitive and motor component processes to physical and instrumental activities of daily living in Parkinson’s disease. Arch Clin Neuropsych. 1998;13:575–583.
  • Schrag A, Jahanshahi M, Quinn N. What contributes to the quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry. 2000;70:425–425.
  • Hobson P, Holden A, Meara J. Measuring the impact of Parkinson’s disease with the Parkinson’s Disease Quality of Life questionnaire. Age Ageing. 1999;28:341–346.
  • Jefferson AL, Paula RH, Ozonoffc A, et al. Evaluating elements of executive functioning as predictors of instrumental activities of daily living (IADLs). Arch Clin Neuropsych. 2006;21:311–320.
  • Bramley N, Eatough V. The experience of living with Parkinson’s disease: an interpretative phenomenological analysis case study. Psychol Health. 2005;20:223–235.
  • Marr JA. The experience of living with Parkinson’s disease. J Neurosci Nurs. 1991;23:325–329.
  • Haahr A, Kirkevold M, Hall EOC, et al. From miracle to reconciliation: a hermeneutic phenomenological study exploring the experience of living with Parkinson’s disease following deep brain stimulation. Int J Nurs Stud. 2010;47:1228–1236.
  • Kudlicka A, Clare L, Hindle JV. Pattern of executive impairment in mild to moderate Parkinson’s disease. Dement Geriatr Cogn Disord. 2013;36:50–66.
  • Hoehn M, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–442.
  • Dubois B, Slachevsky A, Litvan I, et al. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55:1621–1626.
  • Strauss E, Sherman EM, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. New York, NY: Oxford University Press; 2006.
  • Delis DC, Kaplan E, Kramer JH. The Delis-Kaplan executive function system: examiner’s manual. San Antonio: The Psychological Corporation; 2001.
  • Snaith RP, Zigmond AS. HADS: Hospital Anxiety and Depression Scale. Windsor, UK: NFER-Nelson; 1994.
  • Mioshi E, Dawson K, Mitchell J, et al. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriat Psychiatry. 2006;21:1078–1085.
  • Reyes M, Lloret S, Gerscovich E, et al. Addenbrooke’s cognitive examination validation in Parkinson’s disease. Eur J Neurol. 2009;16:142–147.
  • Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
  • Nelson HE, Willison J. National adult reading test manual. 2nd ed. Windsor: NFER-Nelson; 1991.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.
  • Lezak MD. Neuropsychological assessment. 4th ed. New York, NY: Oxford University Press; 2004.
  • Kudlicka A, Clare L, Hindle JV. Awareness of executive deficits in people with Parkinson’s disease. J Int Neuropsychol Soc. 2013;19:559–570.
  • Schiehser DM, Liu L, Lessig SL, et al. Predictors of discrepancies in Parkinson’s disease patient and caregiver ratings of apathy, disinhibition, and executive dysfunction before and after diagnosis. J Int Neuropsychol Soc. 2013;19:295–304.
  • Mathias J. Neurobehavioral functioning of persons with Parkinson’s disease. Appl Neuropsychol. 2003;10:57–68.
  • Bódi N, Kéri S, Nagy H, et al. Reward-learning and the novelty-seeking personality: a between-and within-subjects study of the effects of dopamine agonists on young Parkinson’s patients. Brain. 2009;132:2385–2395.
  • Evans AH, Strafella AP, Weintraub D, et al. Impulsive and compulsive behaviors in Parkinson’s disease. Mov Disord. 2009;24:1561–1570.
  • Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex–basal ganglia circuits. Cereb Cortex. 2006;16:916–928.
  • Santangelo G, Vitale C, Trojano L, et al. Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson’s disease: a prospective longitudinal study. Eur J Neurol. 2015;22:253–260.
  • Santangelo G, Trojano L, Barone P, et al. Apathy in Parkinson’s disease: diagnosis, neuropsychological correlates, pathophysiology and treatment. Behav Neurol. 2013;27:501–513.
  • Blieszner R, Roberto KA, Wilcox KL, et al. Dimensions of ambiguous loss in couples coping with mild cognitive impairment. Family Relat. 2007;56:196–209.
  • Simpson J, McMillan H, Leroi I, et al. Experiences of apathy in people with Parkinson’s disease: a qualitative exploration. Disabil Rehabil. 2015;37:611–619.
  • Bogart KR. Is apathy a valid and meaningful symptom or syndrome in Parkinson’s disease? A critical review. Health Psychol. 2011;30:386.
  • Vlagsma T, Koerts J, Fasotti L, et al. Parkinson’s patients' executive profile and goals they set for improvement: Why is cognitive rehabilitation not common practice? Neuropsychol Rehabil. 2016;26:216–235.
  • Watermeyer TJ, Hindle JV, Roberts J, et al. Goal setting for cognitive rehabilitation in mild to moderate Parkinson’s disease dementia and dementia with Lewy bodies. Parkinsons Dis. 2016;Article ID 8285041:1–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.